Corline Biomedical AB (CLBIO)

Currency in SEK
16.00
-0.60(-3.61%)
Closed·
Earnings results expected in 10 days
CLBIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15.8016.45
52 wk Range
7.9027.20
Key Statistics
Prev. Close
16.6
Open
15.95
Day's Range
15.8-16.45
52 wk Range
7.9-27.2
Volume
15.27K
Average Volume (3m)
22.5K
1-Year Change
56.0976%
Book Value / Share
3.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CLBIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Corline Biomedical AB Company Profile

Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden. The company’s products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used in surgery as an anticoagulant pharmaceutical compound to prevent harmful blood clotting. Its products include Renaparin for use in the treatment of end stage renal failure; Cytoparin, a cell therapy that is used for the treatment of patients with type 1 diabetes; and CHC, which is used for the treatment of soft tissue injuries. The company also provides medical devices, such as coated stents and coated ablation catheter. Corline Biomedical AB was incorporated in 1991 and is based in Uppsala, Sweden.

Employees
13
Market
Sweden

Compare CLBIO to Peers and Sector

Metrics to compare
CLBIO
Peers
Sector
Relationship
P/E Ratio
−17.2x−51.0x−0.5x
PEG Ratio
0.141.310.00
Price/Book
5.3x1.8x2.6x
Price / LTM Sales
46.3x1.0x3.3x
Upside (Analyst Target)
99.4%0.0%45.7%
Fair Value Upside
Unlock28.5%6.5%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 21, 2025
EPS / Forecast
-0.14 / --
Revenue / Forecast
1.30M / 9.70M
EPS Revisions
Last 90 days

CLBIO Income Statement

FAQ

What Is the Corline Biomedical AB (CLBIO) Stock Price Today?

The Corline Biomedical AB stock price today is 16.00

What Stock Exchange Does Corline Biomedical AB Trade On?

Corline Biomedical AB is listed and trades on the Stockholm Stock Exchange.

What Is the Stock Symbol for Corline Biomedical AB?

The stock symbol for Corline Biomedical AB is "CLBIO."

What Is the Corline Biomedical AB Market Cap?

As of today, Corline Biomedical AB market cap is 409.82M.

What Is Corline Biomedical AB's Earnings Per Share (TTM)?

The Corline Biomedical AB EPS (TTM) is -0.99.

When Is the Next Corline Biomedical AB Earnings Date?

Corline Biomedical AB will release its next earnings report on Feb 16, 2026.

From a Technical Analysis Perspective, Is CLBIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Corline Biomedical AB Stock Split?

Corline Biomedical AB has split 2 times.

How Many Employees Does Corline Biomedical AB Have?

Corline Biomedical AB has 13 employees.

What is the current trading status of Corline Biomedical AB (CLBIO)?

As of Feb 07, 2026, Corline Biomedical AB (CLBIO) is trading at a price of 16.00, with a previous close of 16.60. The stock has fluctuated within a day range of 15.80 to 16.45, while its 52-week range spans from 7.90 to 27.20.

What Is Corline Biomedical AB (CLBIO) Price Target According to Analysts?

The average 12-month price target for Corline Biomedical AB is SEK32.00, with a high estimate of SEK32 and a low estimate of SEK32. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +100.00% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.